In 2023, the Long COVID Alliance (co-founded by Solve M.E.) established a new Infection Associated Chronic Conditions Patient Advocacy Coalition (IACC PAC). The Coalition has now produced the Infection-Associated Chronic Conditions Initiative’s (IACCI) Community Resource Guide to strengthen support for individuals experiencing IACCs.| Solve ME/CFS Initiative
As someone living with and managing ME/CFS or Long Covid, we know you have questions. Find answers and links to information here.| Solve ME/CFS Initiative
In August, we announced Solve M.E., in partnership with The Brain Inflammation Collaborative (BIC), the launch of the unhide® Solve Together Unified Platform, a digital health tool designed to uncover […] The post The Unified Platform Now Open to Pediatric Participants appeared first on Solve ME/CFS Initiative.| Solve ME/CFS Initiative
Dr. Dmitri Pchejetski, a researcher at the University of East Anglia Medical School (United Kingdom), has developed a new blood-based assay, the EpiSwitch CFS test, that may prove very effective […] The post Unique Blood-based Test Holds Much Promise for Diagnosing People with ME/CFS appeared first on Solve ME/CFS Initiative.| Solve ME/CFS Initiative
The federal government has shut down, and the impacts are already being felt across systems and services our community depends on. Read our summary of the key areas of impact and tips on ways to stay connected.| Solve ME/CFS Initiative
In July, Solve hosted a webinar featuring representatives of the ADDRESS-LC Trial, which was designed to assess the potential impact of the drug bezisterim on cognitive impairment/brain fog and fatigue […] The post Patient Feedback Spurs Expansion of ADDRESS-LC Trial: More Test Sites, Broader Enrollment appeared first on Solve ME/CFS Initiative.| Solve ME/CFS Initiative
Dr. Per Sjögren, a researcher at the Braggee Myalgic Encephalomyelitis Clinic (Sweden), just published a case series on treating people with ME/CFS by using intravenous saline to relieve dysautonomia, indicating key questions for future clinical trials.| Solve ME/CFS Initiative
Solve M.E. is a non-profit org focused on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid and other post-infection diseases.| Solve ME/CFS Initiative
Hi friends, It’s Monique here, Advocacy Director at Solve M.E., with a progress update on the budget process. We’re right in the thick of appropriations season — when Congress decides […] The post Keeping ME/CFS in the Fight on Capitol Hill appeared first on Solve ME/CFS Initiative.| Solve ME/CFS Initiative
Earlier this year, our partners at the Irish ME/CFS Association for Information, Support and Research asked their members to weigh in on the distribution of monies from their research fund. […] The post Irish ME/CFS Association Donates Over $10k for Solve Research Initiatives appeared first on Solve ME/CFS Initiative.| Solve ME/CFS Initiative
Today, Solve joined #MEAction, Bateman Horne Center, Simmaron Research, Open Medicine Foundation, and other organizations in a sign-on letter urging the National Institutes of Health (NIH) leadership to include subgroup […] The post Solve, Partners Recommend Subgroup Analysis for ME/CFS, POTS, and MCAS in NIH RECOVER TLC Trials appeared first on Solve ME/CFS Initiative.| Solve ME/CFS Initiative
Dr. Avik Roy is the chief scientific officer at the Simmaron Research Institute, a non-profit organization dedicated to understanding ME/CFS and related diseases and to treating people with these diseases. […] The post Simmaron’s Solve ME/CFS Catalyst Award-Winning Rapamycin Trial Yields Promising Treatment Findings appeared first on Solve ME/CFS Initiative.| Solve ME/CFS Initiative
Solve is a proud sponsor of the IACFS/ME Conference and, with our partners at the Brain Inflammation Collaborative (BIC), will co-present a panel on our participant-centered digital health platform for ME, Long Covid, and related conditions and how digital tools can support inclusive research and real-world data collection.| Solve ME/CFS Initiative
Solve President and CEO Emily Taylor, Chief Scientific Officer H. Timothy Hsiao, and Director of Advancement Ilise Friedman recently visited Yale School of Medicine’s Center for Infection & Immunity (CII), the Center Director, Sterling Professor Akiko Iwasaki, and her research team, as coordinated by Dr. Nicole Darricarrère, CII’s Scientific Program Director, in New Haven, CT.| Solve ME/CFS Initiative
Solve M.E. is the proud host and organizer of the annual ME/CFS Advocacy Week. Founded in 2017, this nationwide advocacy effort connects people with ME/CFS, other chronic illnesses, scientists, clinicians and caregivers to share their unique stories with Congress.| Solve ME/CFS Initiative
The largest-ever genetic study of ME/CFS has just revealed its first results — and they could change how we understand the disease. DecodeME’s groundbreaking DNA analysis points to both the immune and nervous systems as key players, offering fresh clues to the roots of this complex condition.| Solve ME/CFS Initiative
“Brain perfusion changes in chronic fatigue syndrome before and after exercise challenge”Principal Investigators: Michael Van Elzakker (PhD) and Kenneth Kwong (PhD)Massachusetts General Hospital, Harvard Medical School Home MICHAEL VAN ELZAKKER […]| Solve ME/CFS Initiative
“Extensive characterization of the ME/CFS blood and cerebrospinal fluid microbiome + virome” Principal Investigators: Nikos Kyripides (PhD) and David Paez-Espino (PhD), DOE Joint Genome Institute and the Lawrence Berkeley National […]| Solve ME/CFS Initiative
The Solve ME/CFS Initiative (Solve M.E.) is a non-profit organization that serves as a catalyst for critical research into diagnostics, treatments, and cures for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid and other post-infection diseases.| Solve ME/CFS Initiative
This Severe ME Day, we're sharing educational resources and teaming up with other ME organizations to raise awareness of severe and very severe ME/CFS.| Solve ME/CFS Initiative
Read our summary of a new RECOVER study co-authored by Solve CEO Emily Taylor examines how social factors affect the chances of getting Long Covid and how addressing those factors could substantially reduce risk.| Solve ME/CFS Initiative
Read our summary of a study by Dr. Akiko Iwasaki and her team that distinguishes groups of people with ME/CFS based on blood-plasma and cerebrospinal fluid proteins.| Solve ME/CFS Initiative
From June 23–27, Advocacy Week 2025, over 200 fierce, compassionate advocates came together from all across the country to make sure one thing was clear: ME/CFS, Long Covid, and related conditions will not be ignored.| Solve ME/CFS Initiative
Solve has selected Simmaron Research as the recipient of our latest ME/CFS Catalyst Award. The funds will be used to accelerate a low-dose rapamycin trial for ME/CFS, Long COVID, and other infection-associated chronic conditions (IACCs). The study advances an FDA-approved drug for reducing key symptoms of ME/CFS and Long Covid, repurposing rapamycin to reduce fatigue, orthostatic intolerance, post-exertional malaise, and sleep issues for a subset of people with ME/CFS.| Solve ME/CFS Initiative
Solve M.E. invests in innovative scientific studies to address knowledge gaps in ME/CFS, Long Covid and other post-infectious diseases.| Solve ME/CFS Initiative
The Solve ME/CFS Initiative (Solve M.E.) is a non-profit organization that serves as a catalyst for critical research into diagnostics, treatments, and cures for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid and other post-infection diseases.| Solve ME/CFS Initiative
In September, the NIH held a three-day workshop at its campus in Bethesda, Maryland, to discuss the path forward for RECOVER-TLC. In this blog, we’re summarizing Day 1 of the workshop in its entirety.| Solve ME/CFS Initiative
Solve M.E. is a non-profit organization focused on ME/CFS, Long Covid and other post-infection diseases.| Solve ME/CFS Initiative
Solve Together is a new platform that brings extensive advantages to the patient community and researchers.| Solve ME/CFS Initiative
A new study in the Journal of the American Medical Association shows that developing long-term ME/CFS-like symptoms is just as likely after being infected with other agents as it is after being infected with SARS-CoV-2. Furthermore, long-term symptoms after other acute infections are as severe as those after SARS-CoV-2 infection. The study illustrates why we must better manage symptoms for all patients with infection-associated chronic diseases and illuminates more ways Long Covid is like ME/...| Solve ME/CFS Initiative
An appropriations sign-on letter is a formal request signed by multiple members of Congress, usually addressed to the leaders of the Appropriations Committees or Subcommittees, urging them to allocate specific funding for particular programs, projects, or initiatives in the federal budget. Learn more about their impact on advocacy.| Solve ME/CFS Initiative
The Long COVID Research Moonshot Act has been introduced! This landmark legislation addresses the urgent needs of millions of Americans suffering from Long Covid and other infection-associated chronic conditions (IACCs), including myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).| Solve ME/CFS Initiative
Dr. Akiko Iwasaki and her team members tested whether autoantibodies in patients with COVID could cause the neurological symptoms of Long Covid.| Solve ME/CFS Initiative
NASEM's report, "A Long COVID Definition: A Chronic, Systemic Disease State with Profound Consequences" is an important step in shortening the path to diagnosis, improving medical education about our category of illnesses, and ensuring that data collection can begin to be streamlined - dramatically improving the quality and ease of research in our field.| Solve ME/CFS Initiative
At Solve M.E., our mission is to drive research and advocacy efforts for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Long Covid, and other infection-associated chronic conditions and illnesses (IACCIs). This year, we have championed three critical appropriations requests to Congress, aiming to secure funding and resources to advance our cause. Two of our appropriations efforts are specific to ME/CFS. Below, we outline the purposes and significance of each of these efforts.| Solve ME/CFS Initiative
Kaine spoke candidly about his three-year Long Covid journey, and what's needed to make real progress for the millions who suffer.| Solve ME/CFS Initiative
